The reversible oral P2Y12 antagonist AZD6140 inhibits ADP-induced contractions in murine and human vasculature

International Journal of Cardiology

Volumn 142, Issue 2, 2010, Pages 187-192

  Högberg, Carl ^a   Svensson, Helen ^a   Gustafsson, Ronny ^a   Eyjolfsson, Atli ^a   Erlinge, David ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Platelets; Receptors; Vasoconstriction

Indexed keywords

2 METHYLTHIOADENOSINE TRIPHOSPHATE; CLOPIDOGREL; TICAGRELOR; ADENOSINE; ADENOSINE DIPHOSPHATE; DRUG DERIVATIVE; P2RY12 PROTEIN, HUMAN; P2RY12 PROTEIN, MOUSE; PURINERGIC P2Y12 RECEPTOR; VASOCONSTRICTOR AGENT;

AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DIAMETER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INTERNAL MAMMARY ARTERY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THORACIC AORTA; ANIMAL; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; MAMMARY ARTERY; METABOLISM; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; SPECIES DIFFERENCE; VASOCONSTRICTION;

ADENOSINE; ADENOSINE DIPHOSPHATE; ADMINISTRATION, ORAL; AGED; ANIMALS; AORTA, THORACIC; FEMALE; HUMANS; MALE; MAMMARY ARTERIES; MICE; RECEPTORS, PURINERGIC P2Y12; SPECIES SPECIFICITY; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 77953293012     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.12.091     Document Type: Article

References (19)

1. Yusuf S., Zhao F., Mehta S.R., Chrolavicius S., Tognoni G., and Fox K.K. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345 (2001) 494-502
2. Chen Z.M., Jiang L.X., Chen Y.P., et al. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 366 (2005) 1607-1621
3. Wiviott S.D., Braunwald E., McCabe C.H., et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357 (2007) 2001-2015
4. Gachet C., and Hechler B. The platelet P2 receptors in thrombosis. Semin Thromb Hemost 31 (2005) 162-167
5. van Giezen J.J., and Humphries R.G. Preclinical and clinical studies with selective reversible direct P2Y12 antagonists. Semin Thromb Hemost 31 (2005) 195-204
6. Husted S.E., Ziegler B.K., and Kher A. Long-term anticoagulant therapy in patients with coronary artery disease. Eur Heart J. 27 (2006) 913-919
7. Cannon C.P., Husted S., Harrington R.A., et al. Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial. J Am Coll Cardiol 50 (2007) 1844-1851
8. Wihlborg A.K., Wang L., Braun O.O., et al. ADP receptor P2Y12 is expressed in vascular smooth muscle cells and stimulates contraction in human blood vessels. Arterioscler Thromb Vasc Biol 24 (2004) 1810-1815
9. Wallentin L., Varenhorst C., James S., et al. Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease. Eur Heart J 29 (2008) 21-30
10. World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. Cardiovasc Res 35 (1997) 2-4
11. Wihlborg A.K., Malmsjö M., Eyjolfsson A., Gustafsson R., Jacobson K., and Erlinge D. Extracellular nucleotides induce vasodilatation in human arteries via prostaglandins, nitric oxide and endothelium-derived hyperpolarising factor. Br J Pharmacol 138 (2003) 1451-1458
12. Borna C., Wang L., Gudbjartsson T., et al. Contractions in human coronary bypass vessels stimulated by extracellular nucleotides. Ann Thorac Surg 76 (2003) 50-57
13. Kasakov L., and Burnstock G. The use of the slowly degradable analog, alpha, beta-methylene ATP, to produce desensitisation of the P2-purinoceptor: effect on non-adrenergic, non-cholinergic responses of the guinea-pig urinary bladder. Eur J Pharmacol 86 (1982) 291-294
14. Malmsjo M., Edvinsson L., and Erlinge D. P2U-receptor mediated endothelium-dependent but nitric oxide-independent vascular relaxation. Br J Pharmacol 123 (1998) 719-729
15. Burnstock G., and Kennedy C. A dual function for adenosine 5'-triphosphate in the regulation of vascular tone. Excitatory cotransmitter with noradrenaline from perivascular nerves and locally released inhibitory intravascular agent. Circ Res 58 (1986) 319-330
16. Shanker G., Kontos J.L., Eckman D.M., Wesley-Farrington D., and Sane D.C. Nicotine upregulates the expression of P2Y12 on vascular cells and megakaryoblasts. J Thromb Thrombolysis 22 (2006) 213-220
17. Savi P., Zachayus J.L., Delesque-Touchard N., et al. The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts. Proc Natl Acad Sci U S A 103 (2006) 11069-11074
18. Simons K., and Ehehalt R. Cholesterol, lipid rafts, and disease. J Clin Invest 110 (2002) 597-603
19. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150